Follow the NxStage Medical, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 12 February 2016 (Levée d'options). Among the most active insiders: Turk Joseph E Jr. Every trade is openly available.
17
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NxStage Medical, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
NxStage Medical, Inc. es una empresa centrada en el desarrollo de tecnologías de diálisis. Su objetivo es mejorar la atención a los pacientes con insuficiencia renal.